|
|
||||||||
1 Pharmacologie et Physico-Chimie des Interactions Cellulaires et Moléculaires, Unité Mixte de Recherche 7034, and 2 Institut de Physiologie et Chimie Biologique, Unité Mixte de Recherche 7519, Centre National de la Recherche Scientifique, Université Louis Pasteur de Strasbourg, 67401 Illkirch, France
| |
ABSTRACT |
|---|
|
|
|---|
The role of adventitial cells in bacterial lipopolysaccharide (LPS)-induced vascular nitric oxide (NO) overproduction has been largely ignored. In rat aortas exposed to LPS in vitro or in vivo, it was found that adventitia contained the major part of NO synthase (NOS)-2 protein (Western blot and immunohistochemistry) and generated the largest amount of NO (electron paramagnetic resonance spin trapping). NOS-2 immunoreactive cells were mainly resident macrophages at an early stage (5 h, in vitro or in vivo) and fibroblasts at a later stage (20 h, in vitro). Adventitial NOS-2 activity largely accounted for 1) the relaxing effect of L-arginine in rings exposed to LPS in vivo, 2) generation of an "NO store" revealed by N-acetylcysteine-induced relaxation, and 3) formation of protein-bound dinitrosyl iron complexes in the medial layer of aortic rings exposed to LPS in vitro. In conclusion, the adventitia is a powerful source of NO triggered by LPS in the rat aorta. This novel source of NO has an important impact on smooth muscle function and might be implicated in various inflammatory diseases.
adventitial fibroblasts; adventitial macrophages; dinitrosyl iron complexes; electron paramagnetic resonance spin trapping
| |
INTRODUCTION |
|---|
|
|
|---|
BLOOD VESSELS EXPOSED TO bacterial lipopolysaccharide (LPS) express inducible nitric oxide (NO) synthase (NOS)-2 and produce large amounts of NO, leading to a dramatic decrease of vascular contractility. In this situation, it is generally assumed that NO is produced by NOS-2 expressed in the endothelium and especially in the vascular smooth muscle cells (VSMC) themselves (14, 23, 25). This assumption is mainly based on the idea that VSMC are the major cell type of the vascular wall and that, like endothelial cells (12), they express NOS-2 in cell culture after proinflammatory stimuli (4, 7). The outer blood vessel layer (tunica adventitia) contains various cell types, including fibroblasts and resident macrophages (20), which are known to express NOS-2 in response to proinflammatory cytokines and/or LPS (16, 28). Recent studies performed in our and other laboratories suggest that the adventitia is an important source of NO in LPS-exposed blood vessels (13, 30). However, direct evidence of potential NOS-2 protein expression and NO production in the adventitia is still lacking. The cell type(s) that expresses NOS-2 as well as the potential functional role of adventitial NO are also illusive.
LPS-induced downregulation of vascular contractility mainly depends on ongoing synthesis of NO via the L-arginine/NOS-2-dependent pathway (8, 10, 14, 23). The high level of NOS-2 activity can lead to the formation of an NO store that, under the influence of thiols, releases NO and contributes to a further decrease of contractility (18). One candidate for such an NO store are protein-bound dinitrosyl iron complexes (DNIC) (18, 19), the formation of which is associated with overproduction of NO (11). The localizations of both vasoactive NO stores and DNIC, as well as the potential sources of NO for their generation in blood vessels, are not fully elucidated.
The purpose of the present study was to examine the degree of expression and the potential functional consequences of adventitial NOS-2 activity. In the rat aorta exposed to LPS, either in vitro or in vivo, we demonstrate that the main part of NOS-2 expression and activity can be attributed to the resident macrophages and fibroblasts within the adventitia. Furthermore, we provide evidence that adventitial NOS-2 activity largely accounts for the LPS-induced downregulatory effect on vascular contraction and potential generation of DNIC in the medial layer.
| |
METHODS |
|---|
|
|
|---|
Materials. Reagents were from Sigma (Saint Quentin-Fallavier, France) unless otherwise indicated.
Aortic preparations and induction of NOS-2. Animal studies were conducted in accordance with the guidelines of the Declaration of Helsinki (authorization no. 01918 given by the French Ministry of Agriculture). Male Wistar rats (11-13 wk) bred in our institute from genitors provided by Iffa Credo (Abresles, France) were killed by cervical dislocation, and thoracic aortas were removed and cleaned of adherent tissues under sterile conditions. Freshly isolated aortas were used as the control. For the in vivo model of NOS-2 induction, rats were treated with LPS (Escherichia coli 055:B5; Difco, Detroit, MI; 40 mg/kg ip) 5 h before they were killed. For the in vitro model, intact aortas or medial layers were incubated for 5 or 20 h in the presence of LPS (10 µg/ml) at 37°C in modified Eagle's medium (MEM; GIBCO) without addition of serum in an incubator gassed with 95% air-5% CO2. Some aortas were incubated with LPS in the presence of 10 µM dexamethasone. Before Western blot analysis, NO spin trapping, and contractile studies, the endothelium was removed by gently rubbing the aortic intimal surface.
Removal of adventitia. In some aortas, adventitial layers were separated from medial layers, according to a previously described technique (3), either before or after exposure to LPS. The thoracic aorta was cleaned of adherent adipose tissue and collateral vessels. After careful cleaning, the adventitial and medial layers could be distinguished at both ends of the aorta under magnification. The dissection was started from the aortic arch-end by splitting of the aortic wall with the use of two microsurgery forceps and gentle peeling of inverted adventitia toward the distal end. When removal of adventitia is performed by a skilled person, the medial layer rings display reproducible contractile properties.
Western blotting.
Samples of adventitia and media stored at
80°C were powdered in
liquid nitrogen. Tissue powder was homogenized at 4°C in 250 mmol/l
NaCl, 25 mmol/l Tris · HCl (pH 7.5), 5 mmol/l EDTA (pH 8.0), 1 mmol/l Pefabloc, 2 µg/ml aprotinin, 2 µg/ml leupeptin, and 2 µg/ml pepstatin (Boehringer) and then sonicated and centrifuged (2 × 10 min at 12,000 g at 4°C). Soluble proteins
(200 µg/lane) were heated for 5 min at 95°C in Laemmli buffer and
electrophoresed along with controls for NOS-2 (1 µg protein of mouse
macrophage lysate), NOS-3 (2 µg protein of human endothelial lysate),
and NOS-1 (2 µg protein of rat pituitary lysate) on SDS-8%
polyacrylamide gels; transferred to nitrocellulose membranes; and
processed for immunoblotting with a polyclonal rabbit antibody against
NOS-2 (1:5,000 dilution from Transduction Laboratories, Lexington, KY). A monoclonal mouse antibody against NOS-1 (1:2,500 dilution from Transduction Laboratories) was used for analysis of NOS-1 expression in
tissue powder homogenized in the above-mentioned buffer supplemented with 1% SDS. Anti-rabbit or anti-mouse IgG horseradish peroxidase conjugates were used as secondary antibodies (1:5,000 dilution; Promega). The immobilized antigens were detected with the use of an
enhanced chemiluminescence assay kit (Amersham). Densitometric analysis
was performed using Starwise software (Imstar, Paris, France). The
signal intensity data are expressed in arbitrary units as means ± SE of three experiments.
Immunohistochemistry.
Aortas were fixed in freshly prepared 4% paraformaldehyde in 0.1 M
PBS, pH 7.4, for 10-15 h. Morphological characterization of
NOS-2-expressing cells was performed on immunoperoxidase-labeled semithin sections. Double labeling with NOS-2 and resident
macrophage-specific antibodies was performed by immunofluorescence on
frozen sections. For semithin sections, 5-mm segments from three
control aortas and three aortas incubated for 20 h with LPS were
dehydrated in graded alcohols and conventionally embedded in an
araldite-epon mixture. Sections, 1-2 µm thick, were prepared on
an OMU3 ultramicrotome (Reichert-Austria) and mounted on gelatin-coated
slides. The embedding medium was removed with sodium methoxide before
application of the avidin-biotin immunoperoxidase technique. Briefly,
the sections were incubated for 30 min in 5% goat serum in PBS with
0.5% Triton X-100 (PBST) and incubated overnight at room temperature
with the polyclonal rabbit antibody against NOS-2 (diluted at 1:250 in
the PBST). They were subsequently treated with biotinylated anti-rabbit
IgG (Amersham) diluted at 1:200 and the peroxidase-avidin biotin
complex (Vectastain Elite kit, Vector) according to the manufacturer's
instructions. Peroxidase was revealed by use of the diaminobenzidine
peroxidase substrate kit (Vector). Sections were dehydrated, cleared in
xylene, coverslipped with Eukitt (Poly Labo), and examined under a
light microscope equipped with Nomarsky optics (Dialux Leitz). For
frozen sections, three aortas of each experimental group were stored
overnight in PBS containing 20% saccharose, embedded in Tissue Tek
(Miles Laboratories), and frozen in isopentane (
50°C). Cross
sections, 10-14 µm thick, were prepared on a cryostat microtome
(Frigocut 2800, Reichert) and thaw-mounted on gelatin-coated slides.
The sections were simultaneously treated with anti-NOS-2 antibody and
monoclonal mouse antibody ED2 (diluted in PBST at 1:250 and 1:200,
respectively). The ED2 antibodies that are specific for rat resident
macrophages (2) were provided by Dr. C. D. Dijkstra
(Free Univ., Amsterdam, The Netherlands). The secondary antibodies were
anti-mouse IgG labeled with fluorescein isothiocyanate and anti-rabbit
IgG labeled with CY3, both raised in the donkey (Jackson) and applied
at a 1:200 dilution. The sections were mounted in Vectashield (Vector)
and examined under an epifluorescence microscope equipped with an
adequate filter system (Dialux Leitz). Some frozen sections were
processed for immunoperoxidase detection of NOS-2, e.g., the semithin
sections, and counterstained with methyl green for visualization of the
NOS-2-negative cells.
NO spin trapping and electron paramagnetic resonance
spectroscopy.
Aortic rings (3-mm long) or corresponding adventitia or media were
incubated in MEM containing L-arginine (L-Arg;
0.6 mmol/l), diethyldithiocarbamate (DETC; 5 mmol/l), ferrous sulfate
(50 µmol/l), and sodium citrate (1 mmol/l) at 37°C for 1 h
(17). Some experiments were performed in the presence of
N
-nitro-L-arginine methyl ester
(L-NAME; 3 mmol/l). After the incubation, tissues were
frozen and then kept in liquid nitrogen. For electron paramagnetic
resonance (EPR) detection of DNIC, whole thoracic aorta (30 mm long) or
corresponding segments of adventitia or media were used. EPR studies
were performed at 77 Kelvin (77 K) on a Bruker 300E
spectrometer with a standard TE102 cavity resonator using a Dewar flask
(Wilmad). EPR parameters were 10 mW of microwave power, 0.6 mT of
amplitude modulation, a 9.45-GHz microwave frequency, and a 100-kHz
modulation frequency. For quantification of the EPR signals, a
paramagnetic solution of
(NO)2Fe(S2O3)2 of known concentration was used. Comparisons were made after double integration of their EPR signals. Amounts of NO trapped by Fe-DETC were expressed either per segment of thoracic aorta (30 mm long) or per microgram of
DNA. The detection limit of the absolute amount of NO-Fe-DETC in the
sample was ~6 pmol. The intra-assay coefficient of variation for EPR
measurement was 4% (n = 10). The interassay
coefficients of variation for NO spin trapping and DNIC were 31 and
34%, respectively (n = 10 samples).
Contraction experiments. Endothelium-denuded aortic rings or rings of medial layer (3-4 mm long) were mounted under a passive tension of 2 g in organ baths (at 37°C) filled with Krebs solution as described previously (8, 10, 18). The effect of L-Arg was studied in rings precontracted with norepinephrine (NE; 1 µmol/l). To reveal the NO store, aortic rings in which adventitia was removed or not, either before or after LPS exposure, were precontracted with NE and L-NAME (3 mmol/l); when the contraction reached a steady-state level, N-acetylcysteine (NAC; 0.1-10 mmol/l) was added in a cumulative manner. The absence of functional endothelium was assessed by the lack of a relaxing effect of ACh (1 µmol/l).
Statistical analysis. Results are expressed as means ± SE of n experiments. Statistical comparisons were made using the nonparametric Mann-Whitney test. P values < 0.05 were considered to be statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Adventitia is the major site of LPS-induced NOS-2 expression.
In control aortas, Western blot analysis (Fig.
1) revealed a trace NOS-2 signal in
adventitia (lane 1) and no NOS-2 signal in media (lane
2). After incubation of isolated aortas with LPS for 20 h,
both aortic layers displayed a strong NOS-2 signal. However, the signal
was stronger in the adventitia than in media (lanes 3 and
4, respectively). No NOS-1 signal was detected in the
adventitia/media samples from either control or LPS-treated aortas (not
shown). In aortas obtained from rats treated with LPS in vivo (5 h),
NOS-2 signals in both layers were markedly less than in the in vitro
model. Again, the NOS-2 signal was stronger in the adventitia than in
media (lanes 5 and 6, respectively).
|
Resident macrophages and fibroblasts are NOS-2-expressing cell
types in adventitia.
No NOS-2-immunoreactive (NOS-2-ir) cells could be detected on semithin
sections of control aortas (Fig.
2A). Aortas incubated with LPS
for 20 h exhibited numerous NOS-2-ir cells regularly distributed
in the adventitia (Fig. 2B). Some labeled
endothelial and subendothelial cells could also be observed. The media
was invariably NOS-2 negative. In the adventitia, most of the NOS-2-ir cells were spindle shaped, with slender and sinuous extensions, which
are characteristic features of fibroblasts. Immunoperoxidase-labeled frozen sections counterstained with methyl green (to visualize all
cellular elements) revealed that after 20 h incubation with LPS,
the great majority of adventitial cells were NOS-2 positive (not
shown). Double immunofluorescence labeling of control aortas did not
reveal the presence of NOS-2-ir cells but showed the presence of
ED2-immunoreactive (ED2-ir) macrophages scattered irregularly in the
adventitia (Fig. 3, A and
B). After 5 h of incubation with LPS, NOS-2-ir cells
appeared in the adventitia. Most of them were ED2-ir macrophages.
However, a few cells were solely NOS-2-ir or ED2-ir (Fig. 3,
C and D). After 20 h of incubation with LPS, NOS-2-ir cells largely outnumbered ED2-ir macrophages (Fig. 3, E and F), indicating that cells other than
resident macrophages predominantly expressed NOS-2. Aortas exposed to
LPS in vivo for 5 h exhibited a double-labeling pattern comparable
with that observed in the 5-h in vitro experiment (Fig. 3, G
and H). As in semithin sections, NOS-2 was also undetectable
in the medial layer in all frozen sections.
|
|
Adventitia is the major site of LPS-induced NO overproduction.
Aortic rings preincubated with LPS for 20 h and then exposed to NO
spin-trap components exhibited the EPR signal with values of
EPR spectroscopic parameter g tensor equal to g
(perpendicular) 2.035 and g
(parallel) 2.02, which are
characteristic of NO-Fe-DETC (27) (Fig. 4A). The
triplet hyperfine structure at g
with hyperfine
splitting from the nitrogen nucleus in the NO ligand AN = 1.3 mT was observed in the EPR signal. A decrease in EPR signals was observed in the presence of 3 mmol/l L-NAME during spin-trapping assay (4-fold decrease; Fig.
4B) or when 10 µmol/l dexamethasone was present during the
incubation period with LPS (8-fold decrease; Fig. 4C).
Rubbing of intimal surface to remove the endothelium before NO assay
led to a decrease in the signals of ~13% (n = 4;
Fig. 4D). No detectable NO was found in control
endothelium-denuded aortic rings (n = 4; not shown). NO
spin-trapping studies were then performed in the adventitia and media
separately. In the in vitro model, adventitia produced an EPR
signal for NO-Fe-DETC that was twice as intensive as the corresponding
segment of media (Fig. 4, E and F, and Table
1). The quantification made per amount of
DNA revealed that one adventitial cell formed about six times more NO
than one cell of medial layer (Table 1). In the in vivo model of
exposure to LPS, EPR detection of NO in the aorta was one order less
than in the in vitro model. Equivalent segments of adventitia and media
gave comparable EPR signals of NO-Fe-DETC. When calculated per DNA,
about three times more NO was detected in the adventitia than media
(Table 1). When the medial layer was exposed to LPS in vitro (in
the absence of adventitia), the rate of NO production was 210 ± 23 pmol · thoracic
aorta
1 · h
1. Thus it is unlikely
that lower medial NO production compared with adventitial NO production
was due to restriction of LPS accessibility to the media by the
adventitia.
|
|
Crucial role of adventitia-derived NO in relaxing effect of
L-Arg.
L-Arg (0.1 mmol/l) caused a profound relaxation of
NE-precontracted adventitia-intact rings obtained from endotoxemic
animals (Fig. 5A). Removal of
the adventitia almost totally abolished the relaxing effect of
L-Arg (Fig. 5B). However, the medial rings showed a profound relaxation in response to the NO donor
S-nitroso-N-acetylpenicillamine (SNAP; 10 µmol/l), indicating that these preparations were responsive to NO.
|
Crucial role of adventitia-derived NO in the formation of NO stores
in the media.
Adventitia-intact rings incubated for 20 h with LPS and
L-Arg (but not those incubated for 5 h; not shown) and
then precontracted with NE plus L-NAME relaxed on addition
of NAC (0.1-10 mmol/l; Fig.
6A). It has been previously
shown that this relaxation was due to an interaction of NAC with a
preformed NO store (18). The relaxing effect of NAC was
still observed in rings subjected to adventitia removal after
incubation with LPS and L-Arg (Fig. 6B).
However, when adventitia removal was performed before the 20-h
incubation with LPS, no relaxation to NAC was observed (Fig. 6C).
|
Crucial role of adventitia-derived NO in the formation of DNIC in
the media.
Preincubation of the whole thoracic aorta with LPS and
L-Arg for 20 h (but not for 5 h; not shown)
resulted in the appearance of a distinct axial EPR signal with
g
= 2.04 and g
= 2.015 (Fig.
7A), which is characteristic
of DNIC bound to sulfur groups of protein(s). The concentration of DNIC
was estimated to be 5.1 ± 0.6 nmol/g. EPR signals for DNIC were
not detected when 20-h incubations were performed in the presence of
L-NAME, in the absence of L-Arg, or in the
absence of LPS (not shown). Removal of the endothelium in aortas after
incubation with LPS and L-Arg did not change the amount of
DNIC (4.9 ± 0.7 nmol/g). The medial layer contained about four
times more DNIC than the adventitia (3.1 ± 0.5 vs. 0.8 ± 0.1 nmol/g, P < 0.01; Fig. 7, B and
C). However, incubation of the media alone in the presence of LPS and L-Arg for 20 h did not result in detectable
DNIC formation (Fig. 7D).
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we demonstrate that within rat aortas exposed to LPS, both in vitro and in vivo, NOS-2 expression and NO production were the highest in the adventitia. NOS-2 was predominantly localized in adventitial resident macrophages and fibroblasts. Moreover, there was an apparent sequence of expression of NOS-2 in the adventitia, starting from macrophages and subsequently involving fibroblasts. In addition, we provide evidence that adventitia-derived NO largely accounts for L-Arg-evoked relaxation and causes generation of a releasable NO store as well as protein-bound DNIC in the medial layer.
Aortic adventitia is a connective tissue layer mainly containing fibroblasts and the much less abundant resident macrophages, mast cells, endothelial cells of vasa vasorum, and Schwann cells associated with nerve axons (20). All of these cells potentially could express NOS-2 and produce large amounts of NO in response to LPS. We found that after 5 h of exposure to LPS (both in vitro and in vivo), most of the NOS-2-expressing cells were resident ED2-ir macrophages, and, vice versa, most ED2-ir macrophages were NOS-2-ir. The similar labeling pattern in in vivo and in vitro experiments pleads against the possibility of massive recruitment of circulating NOS-2-ir cells and suggests a primary role of resident adventitial macrophages at early stages. After incubation of aortas with LPS for 20 h, NOS-2-ir cells largely outnumbered ED2-ir macrophages. As judged from methyl green-counterstained, immunoperoxidase-labeled frozen sections, most adventitial cells were NOS-2-ir, suggesting that fibroblasts were predominantly involved. Convincing evidence for expression of NOS-2 in the fibroblasts might be obtained by use of double staining with NOS-2 antibodies and fibroblast-specific antibodies. However, the fibroblasts are an extremely heterogeneous population, and a general marker for rat fibroblasts is still lacking (21). Nevertheless, on semithin sections of aortas incubated with LPS for 20 h, most NOS-2-ir cells exhibited morphological features of fibroblasts.
Cell culture experiments have shown that macrophages readily express
NOS-2 in response to LPS applied as a single stimulus (16). In contrast, VSMC and fibroblasts actually express
NOS-2 after stimulation with proinflammatory cytokines, such as
interferon -
, tumor necrosis factor, and interleukin-1, alone and/or
in synergistic pairs (4, 7, 28). Because macrophages are known to release various cytokines after contact with bacterial products (26), NOS-2 expression in adventitial fibroblasts
and VSMC might be a secondary event, being under control of
macrophage-derived cytokines. The relative delay of NOS-2 expression in
adventitial fibroblasts is consistent with this possibility.
Immunohistological methods revealed NOS-2 protein only in the
adventitia and in intima but not in the media. A similar observation
was recently reported by another group (30). However,
NOS-2 expression and NO generation in the medial layer were clearly
detected in this study by Western blot and EPR spin trapping,
respectively. The apparent discrepancy of the data obtained by
different methods is unknown. In the immunohistochemical study,
presence of NOS-2 in the medial layer might be underestimated because
of the relatively low sensitivity of the applied techniques. In
addition, in Western blot and EPR spin-trapping studies, the medial
NOS-2/NO might be overestimated because of the potential presence of
NOS-2-expressing intimal and perhaps adventitial cells.
The EPR spin-trapping technique with Fe-DETC as the NO-trapping agent permits direct registration of NO in intact tissue (27). Recently, the expression of the neuronal isoform NOS-1 has been described in the medial and/or adventitial layer of some rat blood vessels (6, 22). However, a substantial contribution of NOS-1-derived NO in our experiments is unlikely, because neither NOS-1 protein nor NO were found in the endothelium-denuded control aorta. In these preparations, the characteristic EPR signals were detected only after exposure to LPS. Additionally, both L-NAME and dexamethasone strongly decreased the signals, suggesting the role of inducible NOS-2 in NO overproduction. It is known that NOS-2 expressed in cultured macrophages generates not only NO but also superoxide anion and peroxynitrite (29). Thus the possibility is not excluded that, under inflammatory conditions, the adventitial NOS-2 may also be an important source of peroxynitrite and other reactive species.
L-Arg-induced relaxation is an intrinsic feature of blood vessels preexposed to LPS (8, 10). Previously, we have shown that, in rat aortas incubated with LPS, this relaxation was largely dependent on the presence of adventitia (13). Here, the crucial role of adventitia in L-Arg-induced relaxation was demonstrated in aortic rings obtained from endotoxemic rats. It is possible that adventitial NO may play a role in the downregulation of vascular contractility in septic shock, as infusion of L-Arg to septic patients leads to a decrease in blood pressure (15). The expression of NOS-2 in the adventitia of omental arteries obtained from some patients with peritonitis and septic syndrome was recently described (24).
Vascular contractility can be depressed not only via NO derived from current NOS activity but also via NO derived from a preformed NO store. The formation of a NO store has been demonstrated after exposure of blood vessels to low-molecular-weight DNIC (19), peroxynitrite (1), or LPS (18). Low-molecular-weight thiols such as NAC can accelerate the release of NO from the NO store, providing a vasorelaxation (18). The fact that NAC produced a relaxing effect in LPS-treated (20 h) aortic rings both before and after removal of the adventitia suggests the presence of an NO store in the medial layer. In contrast, NAC did not induce relaxation in medial rings incubated with LPS. These data suggest the crucial role of adventitia in LPS-induced generation of NO store in media.
There are several candidates for the NO store, including protein-bound DNIC (18, 19). Indeed, in the present study, formation of a NO store in aortas was associated with generation of DNIC. Both events were evident after long-lasting (20 h) incubation with LPS. Interestingly, DNIC were predominantly localized in the media, whereas NOS-2 activity was higher in the adventitia. Because incubation of isolated media with LPS did not result in DNIC formation, these data altogether demonstrate the key role of the adventitia in DNIC formation in the media. The potential role of DNIC in blood vessels deserves further investigation. In addition to its NO-releasing properties, DNIC can exert nitrosative (5) and antioxidant (9) activity. It has also been suggested that DNIC play a role in cytotoxic effects of NO (11).
In conclusion, the present data reveal a new role for resident adventitial cells in the response of the rat aorta to a classical inflammatory stimulus, LPS. In this situation, adventitial macrophages and fibroblasts can potentially express NOS-2 and produce NO in greater amounts than other vascular NO sources. The adventitia-derived NO (or NO-related species) can reach the underlying vascular smooth muscle and may largely account for the downregulation of contraction induced by LPS. Potentially, the large amount of adventitial NO may not only affect contraction but may also initiate many other NO-dependent mechanisms in all three tunica. On the other hand, because of the cytotoxic and cytostatic properties of NOS-2-derived NO (16), the adventitia may become an efficient barrier, preventing the entry of invasive organisms or tumor cells into the circulation. Interestingly, the adventitia occupies 10% of the vascular wall in the thoracic aorta, one-half in muscular arteries, and two-thirds in large veins, and it is absent in arterioles and venules (20). It would be intriguing to speculate that the functional importance of adventitial NOS-2/NO may be proportional to the relative thickness of the adventitia in a given segment of vascular bed.
| |
ACKNOWLEDGEMENTS |
|---|
We are indebted to Dr. C. D. Dijkstra for the gift of ED2 antibodies and to Dr. C. Boulanger for the gift of the NOS-1 monoclonal antibody. We thank Prof. P. Poindron, Dr. G. A. Gray, and Dr. H. Freund for helpful discussion and M. J. Klein and C. Untereiner for technical assistance.
| |
FOOTNOTES |
|---|
This work was supported by the Centre National de la Recherche Scientifique, the European Union Grant Biomed-2 (PL 95 0979), and the Fondation de la Recherche Médicale.
Part of this work has been presented in abstract forms at the British Pharmacological Society, Brighton, UK, December 18-20, 1996, and at the 7th Symposium on Mechanisms of Vasodilatation, Maastricht, The Netherlands, July 6-9, 1997.
Address for reprint requests and other correspondence: A. L. Kleschyov, Laboratory of Pharmacology, U CNRC UMR 7034, Univ. Louis Pasteur de Strasbourg, BP 24, Faculte de Pharmacie, 74 rout du Rhin, 67401 Illkirch, France (E-mail: akleschyov{at}hotmail.com).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 15 November 1999; accepted in final form 22 June 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Balazy, M,
Kaminski PM,
Mao K,
Tan J,
and
Wolin MS.
S-nitrosoglutathione, a product of the reaction between peroxynitrite and glutathione that generates nitric oxide.
J Biol Chem
273:
32009-32015,
1998
2.
Barbé, E,
Damoiseaux JGMC,
Döpp EA,
and
Dijkstra CD.
Characterization and expression of the antigen present on resident rat macrophages recognized by monoclonal antibody ED2.
Immunobiology
182:
88-93,
1990[ISI][Medline].
3.
Battle, T,
Arnal JF,
Challan M,
and
Michel JB.
Selective isolation of rat aortic wall layers and their cell types in culture-application to converting enzyme activity measurement.
Tissue Cell
26:
943-955,
1994[ISI][Medline].
4.
Beasley, D,
Schwartz JH,
and
Brenner BM.
Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
J Clin Invest
87:
602-608,
1991.
5.
Boese, M,
Mordvintcev PI,
Vanin AF,
Busse R,
and
Mülsch A.
S-nitrosation of serum albumin by dinitrosyl-iron complex.
J Biol Chem
270:
29224-29429,
1995
6.
Boulanger, CM,
Heymes C,
Benessiano J,
Geske RS,
Levy BI,
and
Vanhoutte PM.
Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension.
Circ Res
83:
1271-1278,
1998
7.
Busse, R,
and
Mülsch A.
Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.
FEBS Lett
275:
87-90,
1990[ISI][Medline].
8.
Fleming, I,
Gray GA,
Julou-Schaffer G,
Parratt JR,
and
Stoclet JC.
Incubation with endotoxin activates the L-arginine pathway in vascular tissue.
Biochem Biophys Res Commun
171:
562-568,
1990[ISI][Medline].
9.
Gorbunov, NV,
Yalowich JC,
Gaddam A,
Thampatty P,
Ritov VB,
Kisin ER,
Elsayed NM,
and
Kagan VE.
Nitric oxide prevents oxidative damage produced by tert-butylhydroperoxide in erythroleukemia cells via nitrosylation of heme and non-heme iron. Electron paramagnetic resonance evidence.
J Biol Chem
272:
12328-12341,
1997
10.
Gray, GA,
Julou-Schaeffer G,
Oury K,
Fleming I,
Parratt JR,
and
Stoclet JC.
An L-arginine-derived factor mediates endotoxin-induced vascular hyposensitivity to calcium.
Eur J Pharmacol
191:
89-92,
1990[ISI][Medline].
11.
Henry, Y,
Lepoivre M,
Drapier JC,
Ducrocq C,
Boucher JL,
and
Guissani A.
EPR characterization of molecular targets for NO in mammalian cells and organelles.
FASEB J
7:
1124-1134,
1993[Abstract].
12.
Kilbourn, RG,
and
Belloni P.
Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.
J Natl Cancer Inst
82:
772-776,
1990
13.
Kleschyov, AL,
Muller B,
Schott C,
and
Stoclet JC.
Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta.
Br J Pharmacol
123:
623-626,
1998.
14.
Knowles, RG,
Salter M,
Brooks SL,
and
Moncada S.
Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat.
Biochem Biophys Res Commun
172:
1042-1048,
1990[ISI][Medline].
15.
Lorente, JA,
Landin L,
DePablo R,
Renes E,
and
Liste D.
L-Arginine pathway in the sepsis syndrome.
Crit Care Med
21:
1287-1295,
1993[ISI][Medline].
16.
MacMicking, J,
Xie Q,
and
Nathan C.
Nitric oxide and macrophage function.
Annu Rev Immunol
15:
323-350,
1997[ISI][Medline].
17.
Martin, V,
Kleschyov AL,
Klein JP,
and
Beretz A.
Induction of nitric oxide production by polyosides from the cell walls of streptococcus mutans OMZ 175, a gram-positive bacterium, in the rat aorta.
Infect Immun
65:
2074-2079,
1997[Abstract].
18.
Muller, B,
Kleschyov AL,
and
Stoclet JC.
Evidence for N-acetylcysteine-sensitive nitric oxide storage as dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta.
Br J Pharmacol
119:
1281-1285,
1996[ISI][Medline].
19.
Mülsch, A,
Mordvintcev P,
Vanin AF,
and
Busse R.
The potent vasodilating and guanylyl cyclase activating dinitrosyl-iron (II) complex is stored in a protein-bound form in vascular tissue and is released by thiols.
FEBS Lett
294:
252-256,
1991[ISI][Medline].
20.
Rhodin, JAG
Architecture of the vessel wall.
In: Handbook of Physiology. The Cardiovascular System. Vascular Smooth Muscle. Bethesda, MD: Am Physiol Soc, 1980, sect. 2, vol. II, chapt. 1, p. 1-32.
21.
Saalbach, A,
Anderegg U,
Bruns M,
Schnabel E,
Herrmann K,
and
Haustein UF.
Novel fibroblast-specific monoclonal antibodies: properties and specificities.
J Invest Dermatol
106:
1314-1319,
1996[ISI][Medline].
22.
Schwarz, PM,
Kleinert H,
and
Forstermann U.
Potential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta.
Arterioscler Thromb Vasc Biol
19:
2584-2590,
1999
23.
Stoclet, JC,
Fleming I,
Gray GA,
Julou-Schaeffer G,
Schneider F,
Schott C,
and
Parratt JR.
Nitric oxide and endotoxemia.
Circulation
87:
V77-V80,
1993.
24.
Stoclet, JC,
Martinez MC,
Ohlmann P,
Chasserot S,
Schott C,
Kleschyov AL,
Schneider F,
and
Andriantsitohaina R.
Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic schock.
Circulation
100:
107-112,
1999
25.
Titheradge, MA.
Nitric oxide in septic shock.
Biochim Biophys Acta
1411:
437-455,
1999[Medline].
26.
Tracey, K,
and
Cerami A.
Tumor necrosis factor, other cytokines and disease.
Annu Rev Cell Biol
9:
317-343,
1993[ISI].
27.
Vanin, AF,
and
Kleschyov AL.
Nitric Oxide in Allograft Rejection and Anti-Tumor Defense. Norwell, MA: Kluwer Academic, 1998, p. 49-82.
28.
Werner-Felmayer, G,
Werner E,
Fuchs D,
Hausen A,
Reibnegger G,
and
Wachter H.
Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts.
J Exp Med
172:
1599-1606,
1990
29.
Xia, Y,
and
Zweier JL.
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages.
Proc Natl Acad Sci USA
94:
6954-6958,
1997
30.
Zhang, H,
Du Y,
Cohen RA,
Chobanian AV,
and
Brecher P.
Adventitia as a source of inducible nitric oxide synthase in the rat aorta.
Am J Hypertens
12:
467-475,
1999[ISI][Medline].
This article has been cited by other articles:
![]() |
F. A. Auger, P. D'Orleans-Juste, and L. Germain Adventitia contribution to vascular contraction: Hints provided by tissue-engineered substitutes Cardiovasc Res, September 1, 2007; 75(4): 669 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lakshminrusimha, J. A. Russell, S. F. Gugino, R. M. Ryan, B. Mathew, L. C. Nielsen, and F. C. Morin III Adjacent bronchus attenuates pulmonary arterial contractility Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L473 - L478. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Eguchi, L. V. d'Uscio, C. Wambi, D. Weiler, I. Kovesdi, T. O'Brien, and Z. S. Katusic Inhibitory effect of recombinant iNOS gene expression on vasomotor function of canine basilar artery Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2560 - H2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. J. Schulze-Bauer, P. Regitnig, and G. A. Holzapfel Mechanics of the human femoral adventitia including the high-pressure response Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2427 - H2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. J. Schulze-Bauer, P. Regitnig, and G. A. Holzapfel Mechanics of the human femoral adventitia including the high-pressure response Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2427 - H2440. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |